GlobeNewswire 2015-05-27 Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)
GlobeNewswire 2015-05-06 Sobi publishes its Report for the First Quarter 2015
GlobeNewswire 2015-05-04 Early treatment and a longer life - new Orfadin formats meet new patient needs
GlobeNewswire 2015-04-30 Invitation - Presentation of Sobi's first quarter 2015
GlobeNewswire 2015-04-29 Sobi's Board of Directors postpones Annual General Meeting of Shareholders
GlobeNewswire 2015-04-27 Statement regarding recent speculation
GlobeNewswire 2015-04-15 Swedish Orphan Biovitrum AB (publ) : Sobi publishes Annual Report 2014
GlobeNewswire 2015-03-30 Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)
GlobeNewswire 2015-02-27 Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase 3 Alprolix® p...
GlobeNewswire 2015-02-26 Rare Disease Day 2015: Sobi shares study findings on HT-1 adherence in adolescent patients, to high...
GlobeNewswire 2015-02-19 Sobi publishes its Report for the Fourth Quarter and Full Year 2014
GlobeNewswire 2015-02-12 Invitation - Presentation of Sobi's fourth quarter and full year results 2014
GlobeNewswire 2014-12-22 Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease
GlobeNewswire 2014-12-19 Sobi's 2011 Long-Term incentive Programme meets all objectives
GlobeNewswire 2014-12-09 Sobi CEO Geoffrey McDonough sells a portion of 2014 incentive shares
GlobeNewswire 2014-11-21 Sobi exercises opt-in right for Elocta(TM)
GlobeNewswire 2014-10-31 Biogen Idec and Sobi announce European Medicines Agency validates Elocta(TM) (rFVIIIFc) Marketing Au...
GlobeNewswire 2014-10-30 Sobi publishes Report for the Third Quarter 2014
GlobeNewswire 2014-10-16 Invitation - Presentation of Sobi's third quarter results 2014
GlobeNewswire 2014-10-09 Sobi's collaboration partner Biogen Idec files marketing authorisation application for Elocta(TM) (r...
GlobeNewswire 2014-09-22 Sobi opens North American operations
GlobeNewswire 2014-09-19 Sobi expands Haemophilia development portfolio - elects to include potentially longer-acting Haemop...
GlobeNewswire 2014-07-18 Sobi's board of directors exercises authorisation for repurchase of shares for the purpose of securi...
GlobeNewswire 2014-07-18 Sobi publishes Report for the Second Quarter 2014
GlobeNewswire 2014-07-09 Invitation - Presentation of Sobi's second quarter results 2014